Companies

See how salaries can vary from company to company

Drive Shack Inc. owns and operates golf-related leisure and entertainment businesses. Its Entertainment Golf Venues segment operates an entertainment golf venue in Orlando, Florida. This segment also focuses on opening a chain of dining and entertainment golf venues in the United States and internationally, which combine golf, competition, dining, and fun. The company's Traditional Golf Properties segment owns and operates golf properties in the United States. As of December 31, 2018, it owned, leased, or managed 66 properties in 11 states. The company also invests in loans and securities. The... view company details

Aqua America, Inc., through its subsidiaries, operates regulated utilities that provide water or wastewater services in the United States. It offers water services through operating and maintenance contracts with municipal authorities and other parties. The company also provides non-utility raw water supply services for firms in the natural gas drilling industry; and water and sewer line protection solutions, and repair services to households through third-party. It serves approximately three million residential water, commercial water, fire protection, industrial water, wastewater, and other ... view company details

FindEx.com Inc. engages in developing, publishing, marketing, distributing, and direct-selling consumer and organizational software products for the Windows platform. It offers FormTool.com, a software product that is designed for business, accounting, construction, sales, real estate, human resources, and personal organization needs. The company also provides two language-learning software products, such as Greek Tutor and Hebrew Tutor to retail stores, as well as to end users. It markets its products through various online sources, including its formtool.com Website; and other Internet Websi... view company details

Infinite Group, Inc. provides managed information technology (IT) and virtualization services, and develops and provides cybersecurity tools and solutions to private businesses and government agencies in the United States. It offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. The company also provides cloud computing services, including public and private cloud architecture, hybrid cloud hosting, server virtualization, and desktop virtualization solutions; and level 2 Microsoft and Hewlett Packard... view company details

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that is in Phase III clinical trials for the treatment of type 1 and type 2 diabetes; LX9211, which is in Phase Ib clinical development for the treatment of neuropathic pain; and LX276... view company details

Movado Group, Inc. designs, develops, sources, markets, and distributes fine watches in the United States and internationally. The company operates in two segments, Watch and Accessory Brands; and Company Stores. The company offers its watches under the Movado, MVMT, Olivia Burton, Ebel, and Concord brands, as well as under the Coach, Tommy Hilfiger, HUGO BOSS, Lacoste, Scuderia Ferrari, Rebecca Minkoff, and Uri Minkoff licensed brands. It also provides after-sales and shipping service. As of January 31, 2019, the company operated 44 retail outlet locations. Its customers include jewelry store... view company details

Marinus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in three dose forms, including intravenous (IV), oral capsule, and oral liquid for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate exhibits anti-seizure, anti-depression, and anti-anxiety actions through its effects on synaptic a... view company details

Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops peptide-based product candidates to address unmet medical needs in hematology and gastroenterology. The company is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with beta-thalassemia by targeting the chronic anemia; PTG-200, an antagonist peptide product candidate, which has completed Phase I clinical trial to treat inflammatory bowel disease (IBD); and PN-943, an oral, alpha-4-beta-7 specific integrin antagonist that is in Phase I clinical ... view company details

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors... view company details

Ring Energy, Inc., an exploration and production company, acquires, explores for, develops, and produces oil and natural gas in Texas, the United States. As of December 31, 2018, the company's proved reserves consisted of approximately 36.6 million barrel of oil equivalent. As of the above date, it also had interests in 17,408 net developed acres and 58,620 net undeveloped acres in Andrews and Gaines counties; and 19,138 net developed acres and 860 net undeveloped acres in Culberson and Reeves counties. It primarily sells its oil and natural gas production to end users, marketers, and other pu... view company details

Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications. It provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. The company markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment m... view company details

Spirit Airlines, Inc. provides low-fare airline services. The company operates approximately 600 daily flights to 72 destinations in the United States, the Caribbean, and Latin America. As of December 31, 2018, the company had a fleet of 128 Airbus single-aisle aircraft comprising 31 A319s, 60 A320ceos, 7 A320neos, and 30 A321ceos. It offers tickets through its call centers and airport ticket counters, as well as online through spirit.com; and through various third parties, including online, traditional travel agents, and electronic global distribution systems. The company was formerly known a... view company details

XpresSpa Group, Inc. operates as a health and wellness services company in the United States and internationally. It operates through two segments, Wellness and Intellectual Property. The Wellness segment offers airport retailer spa services; massage services for the neck, back, feet, and whole body; nail care, such as pedicures, manicures, and polish changes; travel products, including neck pillows, blankets, and massage tools; and cryotherapy, compression, and personal care services, as well as retail products. This segment offers its wellness and travel products through its Website, xpressp... view company details

Amber Road, Inc. provides cloud-based global trade management (GTM) solutions in the United States and internationally. The company's GTM solutions include modules, such as import management, export management, China trade management, global logistics management, trade agreement management, and supply chain collaboration, as well as professional services, such as assessment, implementation, education and training, and maintenance and support. It provides modules for logistics contract and rate management; supply chain visibility and event management; international trade compliance; and global ... view company details

Arista Networks, Inc. develops, markets, and sells cloud networking solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company's cloud networking solutions consist of extensible operating systems, a set of network applications, as well as gigabit Ethernet switching and routing platforms, including universal leaf, spline, and universal spine products. It also provides post contract customer support services, such as technical support, hardware repair and parts replacement beyond standard warranty, bug fix, patch, and upgrade services. The company serves a rang... view company details

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. The company also offers Game Read, a product for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries; GRPro 2.1, a cold and compression therapy system; Med4Elite... view company details

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in early clinical development stage for the treatment of Arginase 1 deficiency, an autosomal recessive metabolic disease caused by a marked decrease in the activity of the native arginase 1 enzyme; and for treating Arginine dependent cancers. Its preclinical pipeline products comprise AEB4104, a recombi... view company details

Axos Financial, Inc. operates as the holding company for BofI Federal Bank that provides consumer and business banking products in the United States. The company offers deposits products, including consumer and business checking, demand, savings, and time deposit accounts. It also provides single family and multifamily mortgage secured lending products; commercial real estate secured and commercial lending products; specialty finance factoring products; prime loans to customers secured by new and used automobiles; and term unsecured personal loans to individual borrowers, as well as overdraft ... view company details

Booking Holdings Inc. provides online travel and related services in Europe, North America, South America, the Asia-Pacific region, the Middle East, and Africa. The company operates Booking.com, which connects travelers with a selection of places to stay, including apartments, vacation homes, family-run B&Bs, 5-star luxury resorts, tree houses, and igloos; and KAYAK that searches other sites to show travelers the information they need to find the right flights, hotels, rental cars, and vacation packages. It also operates Priceline, an online travel deal service, which provides travelers to sav... view company details

Boston Therapeutics, Inc., a pre-clinical and clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements in the United States. Its lead pharmaceutical drug candidates include BTI-320, a non-systemic, carbohydrate-based compound that is in Phase IIb clinical trial to reduce post-meal elevation of blood glucose levels in Type 2 diabetic and pre diabetic patients; BTI-410, a peptide injectable compound that has completed Phase Ib clinical trials for type 1 immunosuppression therapy after kid... view company details